Page last updated: 2024-08-18

pyrazolanthrone and Cancer of Mouth

pyrazolanthrone has been researched along with Cancer of Mouth in 9 studies

Research

Studies (9)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's3 (33.33)29.6817
2010's6 (66.67)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chiang, IP; Chuang, JY; Huang, YL; Tang, CH; Tsai, MH; Yen, WL1
Reddy, SV; Sambandam, Y; Sundaram, K; Tsuruga, E; Wagner, CL1
Chou, MY; Hu, FW; Lee, SS; Tsai, CH; Wang, TH; Yang, LC; Yu, CC1
Deng, YT; Hsieh, YP; Ko, HH; Kuo, MY; Wu, KJ; Yeh, CC1
Bryne, M; Halstensen, TS; Husvik, C1
Chai, H; Hazawa, M; Hosokawa, Y; Igarashi, J; Kashiwakura, I; Suga, H1
Hayashi, A; Kariya, A; Kondo, T; Tabuchi, Y; Yunoki, T1
Banno, Y; Kato, Y; Kawaguchi, M; Nozawa, Y; Sakai, T1
Aranbayeva, Z; Dickinson, D; Digumarthi, H; Hsu, S; Lewis, J; Messer, R; Osaki, T; Qin, H; Schuster, GS; Wataha, J; Yamamoto, T1

Other Studies

9 other study(ies) available for pyrazolanthrone and Cancer of Mouth

ArticleYear
Syk/JNK/AP-1 signaling pathway mediates interleukin-6-promoted cell migration in oral squamous cell carcinoma.
    International journal of molecular sciences, 2014, Jan-06, Volume: 15, Issue:1

    Topics: Anthracenes; Antibodies, Monoclonal; Carcinoma, Squamous Cell; Cell Line, Tumor; Cell Movement; Humans; Intercellular Adhesion Molecule-1; Interleukin-6; JNK Mitogen-Activated Protein Kinases; Mouth Neoplasms; Phosphorylation; Receptor Protein-Tyrosine Kinases; Receptors, Interleukin-6; RNA Interference; RNA, Small Interfering; Signal Transduction; Transcription Factor AP-1; Up-Regulation

2014
1α,25-dihydroxyvitamin D3 modulates CYP2R1 gene expression in human oral squamous cell carcinoma tumor cells.
    Hormones & cancer, 2014, Volume: 5, Issue:2

    Topics: Anthracenes; Blotting, Western; Calcitriol; Carcinoma, Squamous Cell; Cell Line, Tumor; Cholestanetriol 26-Monooxygenase; Cytochrome P450 Family 2; Gene Expression Regulation, Enzymologic; Gene Expression Regulation, Neoplastic; Humans; Immunohistochemistry; JNK Mitogen-Activated Protein Kinases; Mouth Neoplasms; Proto-Oncogene Proteins c-fos; Proto-Oncogene Proteins c-jun; Receptors, Calcitriol; Reverse Transcriptase Polymerase Chain Reaction; Tissue Array Analysis; Vitamins

2014
Knockdown of S100A4 impairs arecoline-induced invasiveness of oral squamous cell carcinomas.
    Oral oncology, 2015, Volume: 51, Issue:7

    Topics: Anthracenes; Areca; Carcinoma, Squamous Cell; Chromones; Enzyme Inhibitors; Female; Humans; Lymphatic Metastasis; Male; Mastication; Morpholines; Mouth Mucosa; Mouth Neoplasms; Neoplasm Invasiveness; S100 Calcium-Binding Protein A4; S100 Proteins; Survival Rate

2015
Phenethyl isothiocyanate enhances TRAIL-induced apoptosis in oral cancer cells and xenografts.
    Clinical oral investigations, 2016, Volume: 20, Issue:9

    Topics: Acetylcysteine; Animals; Anthracenes; Apoptosis; Blotting, Western; Cell Line, Tumor; Cell Survival; Drug Resistance, Neoplasm; Heterografts; Humans; In Situ Nick-End Labeling; Isothiocyanates; Mice; Mouth Neoplasms; Reactive Oxygen Species; Receptors, TNF-Related Apoptosis-Inducing Ligand; TNF-Related Apoptosis-Inducing Ligand

2016
c-Jun N-terminal kinase negatively regulates epidermal growth factor-induced cyclooxygenase-2 expression in oral squamous cell carcinoma cell lines.
    European journal of oral sciences, 2009, Volume: 117, Issue:6

    Topics: Anthracenes; Calcineurin Inhibitors; Carcinoma, Squamous Cell; Cell Line, Tumor; Cyclooxygenase 2; Cyclosporine; Dactinomycin; Enzyme Inhibitors; Epidermal Growth Factor; Gene Expression Regulation, Enzymologic; Gene Expression Regulation, Neoplastic; Humans; JNK Mitogen-Activated Protein Kinases; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Mouth Neoplasms; NFATC Transcription Factors; p38 Mitogen-Activated Protein Kinases; Phosphorylation; Protein Synthesis Inhibitors; Transcription, Genetic

2009
Novel acridine-based N-acyl-homoserine lactone analogs induce endoreduplication in the human oral squamous carcinoma cell line SAS.
    Biological & pharmaceutical bulletin, 2012, Volume: 35, Issue:8

    Topics: Acridines; Acyl-Butyrolactones; Anthracenes; Antineoplastic Agents; Carcinoma, Squamous Cell; Cell Cycle Checkpoints; Cell Death; Cell Line, Tumor; Cell Survival; Endoreduplication; Humans; JNK Mitogen-Activated Protein Kinases; Mitosis; Mouth Neoplasms; Polyploidy; Protein Serine-Threonine Kinases; Radiation-Sensitizing Agents

2012
The combination of silencing BAG3 and inhibition of the JNK pathway enhances hyperthermia sensitivity in human oral squamous cell carcinoma cells.
    Cancer letters, 2013, Jul-10, Volume: 335, Issue:1

    Topics: Adaptor Proteins, Signal Transducing; Anthracenes; Antineoplastic Agents; Apoptosis; Apoptosis Regulatory Proteins; Carcinoma, Squamous Cell; Cell Line, Tumor; Gene Knockdown Techniques; Heat-Shock Response; Humans; JNK Mitogen-Activated Protein Kinases; MAP Kinase Signaling System; Mouth Neoplasms; RNA Interference; Transcriptional Activation

2013
Pepsin-digested bovine lactoferrin induces apoptotic cell death with JNK/SAPK activation in oral cancer cells.
    Journal of pharmacological sciences, 2005, Volume: 98, Issue:1

    Topics: Animals; Anthracenes; Apoptosis; Cattle; Cell Death; Cell Line, Tumor; Dose-Response Relationship, Drug; Enzyme Activation; Humans; JNK Mitogen-Activated Protein Kinases; Lactoferrin; Mouth Neoplasms; Pepsin A

2005
EGCG-targeted p57/KIP2 reduces tumorigenicity of oral carcinoma cells: role of c-Jun N-terminal kinase.
    Toxicology and applied pharmacology, 2007, Nov-01, Volume: 224, Issue:3

    Topics: Animals; Anthracenes; Apoptosis; bcl-2-Associated X Protein; Blotting, Western; Catechin; Cell Line; Cell Line, Tumor; Cell Proliferation; Cyclin-Dependent Kinase Inhibitor p57; Cytochromes c; Disease-Free Survival; Enzyme Inhibitors; Female; Humans; Imidazoles; JNK Mitogen-Activated Protein Kinases; Mice; Mice, Nude; Mouth Neoplasms; p38 Mitogen-Activated Protein Kinases; Phosphorylation; Pyridines; Signal Transduction; Transfection; Xenograft Model Antitumor Assays

2007